Search - tctmd.com

Displaying 321 - 340 of 877

Sort: Relevancy | Date

News Industry News

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

August 15, 2017

News Daily News

Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared

Todd Neale

August 15, 2017

News Daily News

Air Pollution Tightly Tied to CV Disease, Chinese Study Confirms

Ashley Lyles

August 15, 2017

News Daily News

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

Shelley Wood

August 15, 2017

News Daily News

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Michael O'Riordan

August 14, 2017

News Daily News

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

Yael L. Maxwell

August 14, 2017

News Daily News

When to Say When? Timing of DNR After Cardiac Arrest Varies Widely Among US Hospitals

Yael L. Maxwell

August 11, 2017

News Daily News

Memo for Meta-analyses: Put Quality Over Quantity, Says AHA

Caitlin E. Cox

August 11, 2017

News Daily News

Obese Cardiac Surgery Patients a Burden on ICU Resources

Michael O'Riordan

August 11, 2017

News Daily News

In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs

Shelley Wood

August 10, 2017

News Daily News

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Leah Lawrence

August 10, 2017

News Daily News

Study Links Marijuana Use to Hypertension-Related Death

Ashley Lyles

August 10, 2017

News Daily News

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Michael O'Riordan

August 09, 2017

News Daily News

Readmissions After Acute MI Not Only Confined to the Elderly

Yael L. Maxwell

August 09, 2017

News Daily News

Racial Gap Narrows for In-Hospital Cardiac Arrest Survival

Leah Lawrence

August 09, 2017

News Daily News

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

Michael O'Riordan

August 08, 2017

News Industry News

AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device

August 08, 2017

News Daily News

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Ashley Lyles

August 08, 2017

News Daily News

Safety-Net Hospitals Don’t Lag Behind in Terms of Early PCI Outcomes

Ashley Lyles

August 07, 2017

News Daily News

FDA Deems ‘Field Action’ for Faulty IABPs a Class I Recall

Shelley Wood

August 07, 2017

Advertisement

Medtronic Announces Randomized Global Resolute Onyx(TM) DES One-Month Dual Antiplatelet Therapy Study to Address Critical Unanswered Question in Interventional Cardiology

Costs Up, Usage Down: Hospitals Curtailed Use of CV Meds When Prices Soared

Air Pollution Tightly Tied to CV Disease, Chinese Study Confirms

How Alcohol Hurts and Harms: CVD Sweet Spot Confirmed Anew in Large Meta-Analysis

Early Invasive Strategy Benefits Select High-Risk NSTE ACS Patients, Meta-analysis Suggests

Cardiac Complications of Cancer: Arterial Thromboembolism Risk Doubles With Incident Diagnosis

When to Say When? Timing of DNR After Cardiac Arrest Varies Widely Among US Hospitals

Memo for Meta-analyses: Put Quality Over Quantity, Says AHA

Obese Cardiac Surgery Patients a Burden on ICU Resources

In Case of Emergency: Don’t Rely on ‘Normal’ Range Assays With DOACs

Ad Hoc PCI Safe and Feasible in Patients Undergoing TAVR

Study Links Marijuana Use to Hypertension-Related Death

Reusing the Radial: Repeat Transradial Access Safe and Feasible, Even Within 24 Hours

Readmissions After Acute MI Not Only Confined to the Elderly

Racial Gap Narrows for In-Hospital Cardiac Arrest Survival

Money-Back Guarantee for Evolocumab Has Little Impact on Cost-Effectiveness

AUM Cardiovascular Receives FDA Approval For Revolutionary Diagnostic Heart Device

Permanent Pacemakers Post-TAVR Don’t Increase Adverse Event Risk: Meta-analysis

Safety-Net Hospitals Don’t Lag Behind in Terms of Early PCI Outcomes

FDA Deems ‘Field Action’ for Faulty IABPs a Class I Recall

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content